Unknown

Dataset Information

0

Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes.

ABSTRACT:

SUBMITTER: Kewan T 

PROVIDER: S-EPMC10933698 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes.

Kewan Tariq T   Bahaj Waled W   Durmaz Arda A   Aly Mai M   Ogbue Olisaemeka D OD   Carraway Hetty E HE   Sekeres Mikkael A MA   Visconte Valeria V   Gurnari Carmelo C   Maciejewski Jaroslaw P JP  

Blood 20230401 14

Similar Datasets

Unknown Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
| S-EPMC10414702 | biostudies-literature
Unknown Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification.
| S-EPMC10412560 | biostudies-literature
Unknown Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes.
| S-EPMC4299460 | biostudies-literature
Unknown RBC transfusion dependency refines the Molecular International Prognostic Scoring System for myelodysplastic syndrome.
| S-EPMC12391768 | biostudies-literature
Unknown A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes.
| S-EPMC5728469 | biostudies-literature
Unknown Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.
| S-EPMC6086331 | biostudies-literature
Unknown A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes.
| S-EPMC8759137 | biostudies-literature
Unknown Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.
| S-EPMC5884776 | biostudies-literature
Unknown Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study.
| S-EPMC6312022 | biostudies-literature
Unknown Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.
| S-EPMC3438234 | biostudies-literature